Leaflet MEZYM 20000 250mg gastro-resistant film-coated tablets

Product code:
W43756004
Quantity:
100
Indicated for:
exocrine pancreatic insufficiency; digestive disorders
Route of administration:
oral
Substance:
pancreatin (pancreatic enzyme)
ATC
A09AA02 — Alimentary tract and metabolism | Digestives, incl. enzymes | Digestives, incl. enzymes | Enzyme preparations
Pancreatin is a mixture of digestive enzymes used to aid in the digestion of food when the pancreas does not produce enough enzymes. These enzymes include amylase (for carbohydrate digestion), lipase (for fat digestion), and protease (for protein digestion). Pancreatin is indicated for the treatment of exocrine pancreatic insufficiency associated with conditions such as cystic fibrosis, chronic pancreatitis, pancreatic cancer, or after pancreatic surgery.

Pancreatin is taken orally, usually in the form of capsules or tablets, during or immediately after meals to support food digestion. The dosage is adjusted based on the severity of enzyme deficiency and the patient's diet.

Side effects are rare but may include nausea, diarrhea, constipation, abdominal pain, or allergic reactions. Long-term use of high doses may increase the risk of hyperuricemia (elevated uric acid levels). It is important to use pancreatin as directed by a healthcare provider, and patients should avoid chewing the capsules to prevent irritation of the oral mucosa.

General data about MEZYM 20000 250mg

Substance:
pancreatin
Date of latest medicines list:
01-07-2013
Product code:
W43756004
Concentration:
250mg
Pharmaceutical form:
gastro-resistant film-coated tablets
Quantity:
100
Product type:
Original
Prescription status:
OTC/S

Marketing authorisation

Manufacturer:
BERLIN-CHEMIE AG - GERMANIA
Holder:
BERLIN-CHEMIE AG (MENARINI GROUP) - GERMANIA
Number:
11425/2019/04
Shelf life:
3 years

Concentrations available for pancreatin

  • 125mg
  • 150mg
  • 153.5mg
  • 200mg
  • 250mg
  • 275mg
  • 300mg
  • 325mg
  • 356.100mg
  • 400mg
  • 420mg
  • 90mg